Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases

faida agili200 enrolled

Overview

An observational study aiming to assess the serological profile of SARS-Cov2 patients with systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, inflammatory myopathies, Behçet's disease, Rheumatoid arthritis and Spondyloarthritis

The study is a prospective, observational, multicenter clinical trial to be conducted in the internal medicine, rheumatology and virology departments of Military Hospital of Tunis. After obtaining informed consent from the patient, the investigator will perform an inclusion visit made of a patient interview and performing blood sample to search for IgG and anti-SARS IgM CoV2. Patients with IgM-like antibodies will have an RT-PCR test for active infection. If the study participants will be diagnosed with COVID-19 positive during the study period, the attending physician is entitled to decide on their management based on the severity of the clinical status.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

SARS-CoV Infection Systemic Disease Systemic Lupus Erythematosus Sjogren's Syndrome Sarcoidosis Inflammatory Myopathy

Interventions

Serological testDIAGNOSTIC_TEST

Positive serological test of SARS Cov2

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age over 18 years old * One of the following conditions: systemic lupus, Sjögren's syndrome, rheumatoid arthritis, inflammatory myopathies, spondyloarthritis, sarcoidosis and Behçet's disease. * Informed consent obtained and signed Exclusion Criteria: * Refusal to repeat blood sampling if the first one was badly performed * Informed consent not obained

Locations (1)

Military Hospital of Tunis

Tunis, Tunisia

RECRUITING

Outcomes

Primary Outcomes

Serological Profile

Number of patients with positive serological test of SARS Cov2

Time frame: Inclusion

Central Contacts

Faida Ajili, MD

CONTACT

+21698631188 faida1977@yahoo.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.